Linking Ubiquitin Research to Drug Discovery

Home » News & Events

Targeted chemical libraries: the keys to unlock the ubiquitin system

Posted on September 8th, 2016 in Events
Meet Ubiquigent at the upcoming SCI meeting on the 14th September, Hatfield, UK- Innovation in design, supply and acquisition for compound screening libraries Dr John Harris CChem FRSC, Member of Scientific Advisory Board, Ubiquigent Ltd will be giving a short… Read more

Horizon & Ubiquigent Enter into Collaboration Agreement

Posted on May 26th, 2016 in News
Horizon's X-MAN® cell lines to be made available in conjunction with Ubiquigent's ubiquitin-related Drug Discovery Services   Cambridge, UK, 26 May 2016: Horizon Discovery Group plc (LSE: HZD) ("Horizon"), the world leader in the application of gene editing technologies including… Read more

Dundee, UK – the place to access world class ubiquitin system research expertise and capabilities

Posted on May 12th, 2016 in News
Take a look at a great article that was published today in Nature describing how the Division of Signal Transduction Therapy (DSTT) enables pre-competitive access to ubiquitin system research at the University of Dundee. Our friends at the University of… Read more

Ubiquigent Strengthens Team to Deliver Cutting Edge Drug Discovery Services, Research Tools and Chemistry and Announces Launch of New Website

Posted on February 24th, 2016 in News
Dundee, UK, 24th February, 2016: Ubiquigent Limited, a company specialising in providing ubiquitin cell-signalling system drug discovery services and research tools, announced today that it has significantly enhanced its drug discovery service capabilities by strengthening its commercial and chemistry teams… Read more

6th GTC Ubiquitin research and drug discovery meeting

Posted on February 5th, 2016 in Events
February 29th - March 1st, 2016 San Diego, CA, USA For full conference details click here If you'd like to meet with us at the conference please contact us here

Ubiquitin Signaling with NF-kappaB and MAP Kinase Signaling in Inflammation

Posted on February 5th, 2016 in Events
13-17 March 2016 Whistler Conference Centre Whistler, British Columbia, Canada For full conference details can be found here

Ubiquigent and Cyclofluidic Enter into Collaboration to Build Novel Ubiquitin System Targeted Compound Libraries

Posted on June 3rd, 2015 in News
Agreement combines ubiquitin focused biology expertise with proprietary chemistry platform to identify small molecule libraries that target the ubiquitin system. Dundee, UK, 3rd June 2015: Ubiquigent Limited, a company specialising in ubiquitin cell-signalling system drug discovery capabilities and services, and… Read more

Exclusive collaboration with UbiQ to commercialise novel reagents for Parkinson’s Disease research

Posted on April 29th, 2015 in News
Ubiquigent announces an exclusive collaboration with UbiQ to commercialise novel reagents addressing a new frontier of integrated ubiquitylation and phosphorylation research central to Parkinson's Disease Dundee, UK, 29 April 2015: Ubiquigent Limited, a company specialising in providing ubiquitin cell signalling… Read more

Dr Achim Werner awarded the Ubiquigent Young Scientist Prize

Posted on October 24th, 2014 in News
Dr Achim Werner awarded the Ubiquigent Young Scientist Prize at the EMBO-CONICET meeting on 'Ubiquitin and ubiquitin-like proteins: at the crossroads from chromatin to protein" Dundee, UK, 24th October 2014 - Ubiquigent Ltd. is delighted to announce that Dr Achim Werner was awarded… Read more

Ubiquigent and University of Dundee announce collaboration to develop novel ubiquitin system targeted compound libraries

Posted on October 8th, 2014 in News
Agreement brings together expertise to design, develop and market small molecule libraries targeting ubiquitin system proteins Dundee, UK, 08th October 2014: Ubiquigent Limited, a company specialising in ubiquitin cell-signalling system drug discovery capabilities and services, and the Drug Discovery Unit (the… Read more